ArticleKidney international2022
Anti-CD38 therapy for PLA2R-positive membranous nephropathy resistant to conventional immunosuppression.
Thomas Stehlé et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it
ArticleKidney international2022
Thomas Stehlé et al.PubMed ↗Publisher ↗
No numbers read from the abstract.